Ex-Ante-Transparenzbekanntmachung § 130c Abs. 1 SGB V ATC-Code: A10BK01; ATC-Code: A10BD15
One of 10,000+ tenders Taiyo tracks in Germany.
Source: TED Europa
Arzneimittelrabattvertrag § 130c Abs. 1 SGB V Arzneimittelbezeichnung: FORXIGA Wirkstoff: Dapagliflozin ATC-Code: A10BK01; Arzneimittelbezeichnung: XIGDUO Wirkstoff: Dapagliflozin und Metformin ATC-Code: A10BD15
- Status
- Closed
- Sector
- Hospital
- Location
- Germany
- Updated
- 3 Nov 2026
- Source
- TED Europa
ConstructChat
Ask ConstructChat about Ex-Ante-Transparenzbekanntmachung § 130c Abs. 1 SGB V ATC-Code: A10BK01; ATC-Code: A10BD15
Pick a question to edit it, or write your own.
First answer free · no account
Tender Information FAQ
Tender Information
Participants
| Not available for this record. |
Status
Original status | contract award notice |
Taiyo status | Closed |
Taiyo last update | 2026-11-03 |
Contact
| Not available for this record. |
Description
Description | Arzneimittelrabattvertrag § 130c Abs. 1 SGB V Arzneimittelbezeichnung: FORXIGA Wirkstoff: Dapagliflozin ATC-Code: A10BK01; Arzneimittelbezeichnung: XIGDUO Wirkstoff: Dapagliflozin und Metformin ATC-Code: A10BD15 |
Original sector | Medical equipments, pharmaceuticals and personal care products |
Location
Country | Germany |
Source
Source | TED Europa |
URL |
More Details
Record type | Tender |
Sector | Hospital |
Article published date | 2026-07-24 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this tender
- News and media coverage
- Technical research
Free account · no card · lands you back on this tender